It is reported that Isomorphic Labs, an AI drug discovery company under Alphabet, is seeking financing at a valuation of 40 to 50 billion US dollars
Isomorphic Labs conducted a Series B financing this May, raising 2.1 billion dollars from investors including its parent company.
Return to original text
A short introduction is retained here; the full text from the source website is not reposted. For specific wording and subsequent updates, please refer to the original article.
Open the original article on ITHome